3 天
Health on MSNWhat's the Difference Between Asthma and Chronic Obstructive Pulmonary Disease (COPD)?Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...
Wellinks has joined forces with Careabout Health to introduce its virtual COPD management program to the New Jersey and ...
CareAbout will incorporate Wellinks’ value-based COPD management programs, which include virtual pulmonary rehabilitation, remote monitoring, and ongoing care management, all designed to improve ...
5 天
HealthDay on MSNCOPD Tied to Increased Risk of Mortality in Patients With ArthritisAdults with arthritis and chronic obstructive pulmonary disease (COPD) have a higher risk for mortality than individuals without COPD.
6 天
Pharmaceutical Technology on MSNEMA to review GSK’s Nucala for COPD treatment expansionThe EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.
Paris and Tarrytown, NY, March 28, 2025. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic ...
Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.
A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.
While smoking is a major risk factor for COPD, other risk factors like environmental, occupational, and early life factors ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果